HomeTELO • CVE
add
Telo Genomics Corp
Previous close
$0.055
Year range
$0.045 - $0.16
Market cap
5.52M CAD
Avg Volume
61.71K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 671.92K | 12.34% |
Net income | -706.66K | -17.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -669.04K | -13.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 789.29K | -0.85% |
Total assets | 911.30K | -5.63% |
Total liabilities | 396.32K | 5.52% |
Total equity | 514.98K | — |
Shares outstanding | 99.97M | — |
Price to book | 5.50 | — |
Return on assets | -145.50% | — |
Return on capital | -205.10% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -706.66K | -17.92% |
Cash from operations | -459.40K | 8.92% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -459.40K | -536.95% |
Free cash flow | -481.73K | -61.53% |
About
Founded
2011
Headquarters
Website
Employees
8
